Daiichi Sankyo Korea's corporate ideology is to contribute to the healthy and prosperous life of its people by continuously providing innovative medicines based on the realization of the Daiichi Sankyo Group's "Global Pharma Innovator with Competitiveness in Anti-cancer drugs."

Daiichi Sankyo Korea will continue to strengthen its expertise and leadership in the cardiovascular drug market based on the vision and pipeline of Daiichi Sankyo, and the strengths of Daiichi Sankyo Korea, while strengthening its competitiveness in the field of anticancer drugs with high unmet medical needs.